Wednesday - July 02, 2025

Category Archives: Europe

Non-small Cell Lung Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | GlaxoSmithKline, Novartis, AstraZeneca, Eli Lilly and Company

Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight 2025 DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) – Pipeline Insight, 2025,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipeline drug profiles, … Continue reading →

Amyotrophic Lateral Sclerosis Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Ionis Pharmaceuticals, 1ST Biotherapeutics, Scholar Rock

Amyotrophic Lateral Sclerosis (ALS) Pipeline Insight 2025 DelveInsight’s, “Amyotrophic Lateral Sclerosis (ALS) – Pipeline Insight, 2025,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis (ALS) pipeline landscape. It covers the pipeline drug profiles, … Continue reading →

ETFE & ECTFE Coatings Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2030

The ETFE & ECTFE coatings market is gaining momentum due to their exceptional chemical resistance, thermal stability, and non-stick properties, making them ideal for industrial, chemical processing, and architectural applications. With increasing demand across end-use industries, key players such as … Continue reading →

Hepatorenal Syndrome Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Noorik Biopharmaceuticals, Cumberland Pharmaceuticals

Hepatorenal syndrome Pipeline Insight 2025 DelveInsight’s, “Hepatorenal syndrome – Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Hepatorenal syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Hepatitis D Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Eiger Biopharmaceuticals, Arrowhead Pharmaceuticals, Antios Therapeutics, PharmaEsse

Hepatitis D Pipeline Analysis DelveInsight’s, “Hepatitis D – Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Hepatitis D pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Chronic Inducible Urticaria Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Celldex Therapeutics, Jasper Therapeutics

Chronic Inducible Urticaria Pipeline Analysis “DelveInsight’s, “Chronic Inducible Urticaria – Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Chronic Inducible Urticaria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading →

Non-alcoholic Steatohepatitis (NASH) Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Guangdong Raynovent Biotech, Dr. Falk Pharma GmbH

Non-alcoholic Steatohepatitis (NASH) Pipeline Analysis Non-alcoholic Steatohepatitis (NASH) Companies are Viking Therapeutics, Eli Lilly and Company, Sagimet Biosciences, Terns, Sinew Pharma, Madrigal Pharmaceuticals, Hepion Pharmaceuticals, Poxel SA, Pfizer, CytoDyn, Altimmune, Oramed, Ltd, PharmaKing, Can-Fite Biopharma, Cirius Therapeutics, and others. Non-alcoholic … Continue reading →